Obtaining approval for a clinical trial is no easy feat. A combination of scientific vision, managerial skill, and an awareness of the responsibility owed both to the research as well as to the patients being treated is needed. We offer our congratulations to these researchers on their success in securing support for their upcoming clinical trials. (This is not a comprehensive list.)
Sue Bodine, PhD
Professor in the Division of Endocrinology and Metabolism
Trial: “Splanchno-Hormonal Mechanisms of Cystic Fibrosis Related Diabetes”
Source: National Institutes of Health
Shobha Chitneni, MD
Clinical Assistant Professor in the Division of Hematology, Oncology, and Blood & Marrow Transplantation
Trial: “A phase III, open-label, randomized study of atezolizumab in combination with carboplatin + paclitaxel with or without bevacizumab compared with carboplatin + paclitaxel + bevacizumab in chemotherapy-naïve patients with stage IV”
Source: Genentech, Inc.
Diana Jalal, MD
Clinical Associate Professor in the Division of Nephrology and Hypertension
Trial: “Curcumin Supplementation for Improving Vascular and Cognitive Function”
Source: National Institutes of Health
Margarida Magalhaes-Silverman, MD
Clinical Professor in the Division of Hematology, Oncology, and Blood & Marrow Transplantation
Trial: “GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids for the Treatment of First-Line Acute Graft-vs-Host Disease”
Source: Incyte Corporation
Congratulations and best wishes on the road to scientific discovery!